Literature DB >> 17521647

Endoscopic management of biliopleural fistula and biloma after percutaneous radiofrequency ablation of liver metastasis.

Vito Pende1, Michele Marchese, Massimiliano Mutignani, Umberto Polinari, Carlo Allegri, Raffaele Greco, Guido Costamagna.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17521647     DOI: 10.1016/j.gie.2006.12.023

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  5 in total

1.  Percutaneous management of a bronchobiliary fistula after radiofrequency ablation in a patient with hepatocellular carcinoma.

Authors:  Dok Hyun Yoon; Ju Hyun Shim; Wook Jin Lee; Pyo Nyun Kim; Ji Hoon Shin; Kang Mo Kim
Journal:  Korean J Radiol       Date:  2009-06-25       Impact factor: 3.500

2.  Delayed bronchobiliary fistula following radiofrequency ablation in a patient with hepatocellular carcinoma: A case report and lesson regarding treatment.

Authors:  Zhaolin Zeng; Mingyue Cai; Wensou Huang; Jingjun Huang; Xiuzhen Chen; Hong Shan; Kangshun Zhu
Journal:  Oncol Lett       Date:  2016-03-22       Impact factor: 2.967

3.  Surgical treatment of bronchobiliary fistula due to radiofrequency ablation for recurrent hepatocellular carcinoma.

Authors:  Dong Hun Kim; Dong Wook Choi; Seong Ho Choi; Jin Seok Heo; Jaehong Jeong; Jinsoo Rhu
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2013-08-31

4.  Use heat with caution! Pleurobiliary fistula after hepatocellular carcinoma microwave ablation in lymphoma patient: A case study.

Authors:  Etedal Abdurabuh; Mutaz Khairo; Aquib Bakhsh; May Alsharif; Wael AlYamani
Journal:  Radiol Case Rep       Date:  2022-08-10

Review 5.  Bronchobiliary fistula after ablation of hepatocellular carcinoma adjacent to the diaphragm: Case report and literature review.

Authors:  Zhi-Mei Huang; Meng-Xuan Zuo; Yang-Kui Gu; Chun-Xiao Lai; Qiu-Xiang Pan; Xiao-Cheng Yi; Tian-Qi Zhang; Jin-Hua Huang
Journal:  Thorac Cancer       Date:  2020-03-09       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.